Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer

Molecular Aspects of Medicine

Volumn 27, Issue 2-3, 2006, Pages 192-223

  Bustin, Stephen A ^a,c   Mueller, Reinhold ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b RT Consultancy   (United States)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Cancer; Colon; Occult disease

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; GUANYLATE CYCLASE; MESSENGER RNA; TUMOR MARKER;

BIOPSY; BODY FLUID; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MONITORING; NONHUMAN; OCCULT CANCER; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; TREATMENT RESPONSE;

COLORECTAL NEOPLASMS; COMPUTER SYSTEMS; FORECASTING; HUMANS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33644917430     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2005.12.002     Document Type: Review

References (177)

1. L.V. Abruzzo, J. Wang, M. Kapoor, L. Jeffrey Medeiros, M.J. Keating, W. Edward Highsmith, L.L. Barron, C.C. Cromwell, and K.R. Coombes Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays J. Mol. Diagn. 7 2005 337 345
2. M.A. Afzal, A.D. Osterhaus, S.L. Cosby, L. Jin, J. Beeler, K. Takeuchi, and H. Kawashima Comparative evaluation of measles virus-specific RT-PCR methods through an international collaborative study J. Med. Virol. 70 2003 171 176
3. S. Akilesh, D.J. Shaffer, and D. Roopenian Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis Genome Res. 13 2003 1719 1727
4. C.L. Andersen, J.L. Jensen, and T.F. Orntoft Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets Cancer Res. 64 2004 5245 5250
5. P. Anker, F. Lefort, V. Vasioukhin, J. Lyautey, C. Lederrey, X.Q. Chen, M. Stroun, H.E. Mulcahy, and M.J. Farthing K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer Gastroenterology 112 1997 1114 1120
6. B. Baisse, H. Bouzourene, E.P. Saraga, F.T. Bosman, and J. Benhattar Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma Int. J. Cancer 93 2001 346 352
7. P.E. Barker, M.S. Watson, J.R. Ticehurst, J.C. Colbert, and C.D. O'Connell NIST physical standards for DNA-based medical testing J. Clin. Lab. Anal. 16 2002 5 10
8. A. Bas, G. Forsberg, S. Hammarstrom, and M.L. Hammarstrom Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate- dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes Scand. J. Immunol. 59 2004 566 573
9. X. Bessa, J.I. Elizalde, L. Boix, V. Pinol, A.M. Lacy, J. Salo, J.M. Pique, and A. Castells Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer Gastroenterology 120 2001 1084 1092
10. P. Bhatia, W.R. Taylor, A.H. Greenberg, and J.A. Wright Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S- ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential Anal. Biochem. 216 1994 223 226
11. P.J. Bostick, S. Chatterjee, D.D. Chi, K.T. Huynh, A.E. Giuliano, R. Cote, and D.S. Hoon Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients J. Clin. Oncol. 16 1998 2632 2640
12. P.J. Bostick, D.S. Hoon, and R.J. Cote Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer N. Engl. J. Med. 339 1998 1643 1644
13. F.G. Bottone Jr., J.M. Martinez, J.B. Collins, C.A. Afshari, and T.E. Eling Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis J. Biol. Chem. 278 2003 25790 25801
14. P. Boyle, and J. Ferlay Cancer incidence and mortality in Europe, 2004 Ann. Oncol. 16 2005 481 488
15. S.A. Burchill, M.F. Bradbury, K. Pittman, J. Southgate, B. Smith, and P. Selby Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction Br. J. Cancer 71 1995 278 281
16. S.A. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J. Mol. Endocrinol. 25 2000 169 193
17. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J. Mol. Endocrinol. 29 2002 23 39
18. S.A. Bustin A-Z of quantitative PCR 2004 IUL Press La Jolla, CA
19. S.A. Bustin Real-time, fluorescence-based quantitative PCR: a snapshot of current procedures and preferences Expert Rev. Mol. Diagn. 5 2005 493 498
20. S.A. Bustin, and S. Dorudi Molecular assessment of tumour stage and disease recurrence using PCR- based assays Mol. Med. Today 4 1998 389 396
21. S.A. Bustin, and R. Mueller Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis Clin. Sci. (London) 109 2005 365 379
22. S.A. Bustin, and T. Nolan Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction J. Biomol. Tech. 15 2004 155 166
23. S.A. Bustin, V.G. Gyselman, N.S. Williams, and S. Dorudi Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients Br. J. Cancer 79 1999 1813 1820
24. S.A. Bustin, V.G. Gyselman, S. Siddiqi, and S. Dorudi Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients Int. J. Surg. Invest. 2 2000 49 57
25. S.A. Bustin, S. Siddiqi, S. Ahmed, R. Hands, and S. Dorudi Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients Int. J. Cancer 108 2004 412 417
26. B. Cagir, A. Gelmann, J. Park, T. Fava, A. Tankelevitch, E.W. Bittner, E.J. Weaver, J.P. Palazzo, D. Weinberg, R.D. Fry, and S.A. Waldman Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer Ann. Intern. Med. 131 1999 805 812
27. R. Calaluce, B.W. Miedema, and Y.W. Yesus Micrometastasis in colorectal carcinoma: a review J. Surg. Oncol. 67 1998 194 202
28. S.L. Carrithers, S.J. Parkinson, S. Goldstein, P. Park, D.C. Robertson, and S.A. Waldman Escherichia coli heat-stable toxin receptors in human colonic tumors Gastroenterology 107 1994 1653 1661
29. S.L. Carrithers, M.T. Barber, S. Biswas, S.J. Parkinson, P.K. Park, S.D. Goldstein, and S.A. Waldman Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues Proc. Natl. Acad. Sci. USA 93 1996 14827 14832
30. S.L. Carrithers, S.J. Parkinson, S.D. Goldstein, P.K. Park, R.W. Urbanski, and S.A. Waldman Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors Dis. Colon Rectum 39 1996 171 181
31. A. Castells, L. Boix, X. Bessa, L. Gargallo, and J.M. Pique Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction Br. J. Cancer 78 1998 1368 1372
32. P. Champelovier, F. Mongelard, and D. Seigneurin CK20 gene expression: technical limits for the detection of circulating tumor cells Anticancer Res. 19 1999 2073 2078
33. G. Chen, C.M. McIver, M. Texler, J.M. Lloyd, N. Rieger, P.J. Hewett, D. Sen Wan, and J.E. Hardingham Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study Dis. Colon Rectum 47 2004 679 686
34. W.S. Chen, M.Y. Chung, J.H. Liu, J.M. Liu, and J.K. Lin Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery World J. Surg. 28 2004 552 557
35. S.Y. Chun, O.S. Bae, and J.B. Kim The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes J. Korean Med. Sci. 15 2000 696 700
36. G.A. Clarke, E. Ryan, J.P. Crowe, J.C. O'Keane, and P. MacMathuna Tumour-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death Int. J. Colorectal Dis. 16 2001 108 111
37. M. Conzelmann, C.P. Dieterle, U. Linnemann, and M.R. Berger Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients Int. J. Cancer 107 2003 617 628
38. N.J. Coombs, A.C. Gough, and J.N. Primrose Optimisation of DNA and RNA extraction from archival formalin-fixed tissue Nucleic Acids Res. 27 1999 e12
39. M. Cronin, K. Ghosh, F. Sistare, J. Quackenbush, V. Vilker, and C. O'Connell Universal RNA reference materials for gene expression Clin. Chem. 50 2004 1464 1471
40. J.B. de Kok, R.W. Roelofs, B.A. Giesendorf, J.L. Pennings, E.T. Waas, T. Feuth, D.W. Swinkels, and P.N. Span Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes Lab. Invest. 85 2005 154 159
41. W.J. de Leeuw, P.E. Slagboom, and J. Vijg Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control Nucleic Acids Res. 17 1989 10137 10138
42. K. Dheda, J.F. Huggett, S.A. Bustin, M.A. Johnson, G. Rook, and A. Zumla Validation of housekeeping genes for normalizing RNA expression in real-time PCR Biotechniques 37 2004 112 114 116, 118-119
43. K. Dheda, J.F. Huggett, J.S. Chang, L.U. Kim, S.A. Bustin, M.A. Johnson, G.A. Rook, and A. Zumla The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization Anal. Biochem. 344 2005 141 143
44. Z. Dobbie, P.Y. Muller, K. Heinimann, C. Albrecht, D. D'Orazio, I. Bendik, H. Muller, and P. Bauerfeind Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam Anticancer Res. 22 2002 2215 2220
45. S. Dorudi, E. Kinrade, N.C. Marshall, R. Feakins, N.S. Williams, and S.A. Bustin Genetic detection of lymph node micrometastases in patients with colorectal cancer Br. J. Surg. 85 1998 98 100
46. R. Douard, S. Moutereau, V. Serru, J.P. Sales, P. Wind, P.H. Cugnenc, M. Vaubourdolle, and S. Loric Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients Clin. Chem. Lab. Med. 43 2005 127 132
47. D.C. Farrugia, H.E. Ford, D. Cunningham, K.D. Danenberg, P.V. Danenberg, J. Brabender, A.D. McVicar, G.W. Aherne, A. Hardcastle, K. McCarthy, and A.L. Jackman Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed Clin. Cancer Res. 9 2003 792 801
48. T.A. Fava, R. Desnoyers, S. Schulz, J. Park, D. Weinberg, E. Mitchell, and S.A. Waldman Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood J. Clin. Oncol. 19 2001 3951 3959
49. I.J. Fidler Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture Cancer Res. 50 1990 6130 6138
50. I.J. Fidler Host and tumour factors in cancer metastasis Eur. J. Clin. Invest. 20 1990 481 486
51. B. Frech, and E. Peterhans RT-PCR: "background priming" during reverse transcription Nucleic Acids Res. 22 1994 4342 4343
52. N.O. Funaki, J. Tanaka, A. Itami, T. Kasamatsu, G. Ohshio, H. Onodera, K. Monden, T. Okino, and M. Imamura Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA Life Sci. 60 1997 643 652
53. H. Funaki, G. Nishimura, S. Harada, I. Ninomiya, I. Terada, S. Fushida, T. Tani, T. Fujimura, M. Kayahara, K. Shimizu, T. Ohta, and K. Miwa Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma Oncology 64 2003 416 422
54. J. Gabert, E. Beillard, V.H. van der Velden, W. Bi, D. Grimwade, N. Pallisgaard, G. Barbany, G. Cazzaniga, J.M. Cayuela, H. Cave, F. Pane, J.L. Aerts, D. De Micheli, X. Thirion, V. Pradel, M. Gonzalez, S. Viehmann, M. Malec, G. Saglio, and J.J. van Dongen Standardization and quality control studies of "real-time" quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer program Leukemia 17 2003 2318 2357
55. R. Gertler, R. Rosenberg, D. Stricker, M. Werner, S. Lassmann, K. Ulm, H. Nekarda, and J.R. Siewert Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma Cancer 95 2002 2103 2111
56. R.A. Ghossein, and S. Bhattacharya Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours Eur. J. Cancer 36 2000 1681 1694
57. J.C. Goeminne, T. Guillaume, M. Salmon, J.P. Machiels, V. D'Hondt, and M. Symann Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors Bone Marrow Transplant. 24 1999 769 775
58. D.C. Gotley, J. Fawcett, M.D. Walsh, J.A. Reeder, D.L. Simmons, and T.M. Antalis Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer Br. J. Cancer 74 1996 342 351
59. F. Guadagni, M. Roselli, M. Cosimelli, A. Spila, F. Cavaliere, R. Arcuri, R. D'Alessandro, P.L. Fracasso, V. Casale, A. Vecchione, C.U. Casciani, J.W. Greiner, and J. Schlom Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlation Int. J. Cancer 72 1997 949 954
60. F. Guadagni, J. Kantor, S. Aloe, M.D. Carone, A. Spila, R. D'Alessandro, M.R. Abbolito, M. Cosimelli, F. Graziano, F. Carboni, S. Carlini, P. Perri, F. Sciarretta, J.W. Greiner, S.V. Kashmiri, S.M. Steinberg, M. Roselli, and J. Schlom Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers Cancer Res. 61 2001 2523 2532
61. U. Guller, P. Zajac, A. Schnider, B. Bosch, S. Vorburger, M. Zuber, G.C. Spagnoli, D. Oertli, R. Maurer, U. Metzger, F. Harder, M. Heberer, and W.R. Marti Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer Ann. Surg. 236 2002 768 775
62. J. Gunn, J.L. McCall, K. Yun, and P.A. Wright Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction Lab. Invest. 75 1996 611 616
63. U. Gunthert, M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell 65 1991 13 24
64. J. Guo, B. Xiao, Z. Jin, L. Qin, J. Chen, H. Chen, X. Zhang, and Z. Liu Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymerase chain reaction J. Gastroenterol. Hepatol. 20 2005 1279 1284
65. B. Gyorffy, P. Surowiak, O. Kiesslich, C. Denkert, R. Schafer, M. Dietel, and H. Lage Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations Int. J. Cancer 2005
66. R. Hampton, M. Walker, J. Marshall, and H. Juhl Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells Oncogene 21 2002 7817 7823
67. J.E. Hardingham, P.J. Hewett, R.E. Sage, J.L. Finch, J.D. Nuttall, D. Kotasek, and A. Dobrovic Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease Int. J. Cancer 89 2000 8 13
68. N.J. Hawkins, I. Tomlinson, A. Meagher, and R.L. Ward Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer Br. J. Cancer 84 2001 232 236
69. N. Hayashi, I. Ito, A. Yanagisawa, Y. Kato, S. Nakamori, S. Imaoka, H. Watanabe, M. Ogawa, and Y. Nakamura Genetic diagnosis of lymph-node metastasis in colorectal cancer Lancet 345 1995 1257 1259
70. C.A. Heid, J. Stevens, K.J. Livak, and P.M. Williams Real time quantitative PCR Genome Res. 6 1996 986 994
71. E. Heinmoller, B. Renke, K. Beyser, W. Dietmaier, C. Langner, and J. Ruschoff Pitfalls in diagnostic molecular pathology-significance of sampling error Virchows. Arch. 439 2001 504 511
72. P. Hermanek pTNM and residual tumor classifications: problems of assessment and prognostic significance World J. Surg. 19 1995 184 190 (Review, 45 references)
73. S.B. Ho, A. Hyslop, R. Albrecht, A. Jacobson, M. Spencer, D.A. Rothenberger, G.A. Niehans, J. D'Cunha, and R.A. Kratzke Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen Clin. Cancer Res. 10 2004 5777 5784
74. J. Huggett, K. Dheda, S. Bustin, and A. Zumla Real-time RT-PCR normalisation; strategies and considerations Genes Immun. 6 2005 279 284
75. W. Ichikawa, H. Uetake, Y. Shirota, H. Yamada, N. Nishi, Z. Nihei, K. Sugihara, and R. Hirayama Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer Clin. Cancer Res. 9 2003 786 791
76. W. Ichikawa, H. Uetake, Y. Shirota, H. Yamada, T. Takahashi, Z. Nihei, K. Sugihara, Y. Sasaki, and R. Hirayama Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer Br. J. Cancer 89 2003 1486 1492
77. M. Inokuchi, H. Uetake, Y. Shirota, H. Yamada, M. Tajima, and K. Sugihara Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis Cancer Chemother. Pharmacol. 53 2004 391 396
78. S. Ito, H. Nakanishi, T. Hirai, T. Kato, Y. Kodera, Z. Feng, Y. Kasai, K. Ito, S. Akiyama, A. Nakao, and M. Tatematsu Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler Cancer Lett. 183 2002 195 203
79. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer, and M.J. Thun Cancer statistics, 2005 CA Cancer J. Clin. 55 2005 10 30
80. P.G. Johnston Stage II colorectal cancer: to treat or not to treat Oncologist 10 2005 332 334
81. S. Jonas, S. Windeatt, A. O-Boateng, C. Fordy, and T.G. Allen-Mersh Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction Gut 39 1996 717 721
82. R. Jung, K. Petersen, W. Kruger, M. Wolf, C. Wagener, A. Zander, and M. Neumaier Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes Br. J. Cancer 81 1999 870 873
83. R. Jung, K. Soondrum, W. Kruger, and M. Neumaier Detection of micrometastasis through tissue-specific gene expression: its promise and problems Recent Res. Cancer Res. 158 2001 32 39
84. M. Kawakami, T. Furuhata, Y. Kimura, K. Yamaguchi, F. Hata, K. Sasaki, and K. Hirata Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer J. Exp. Clin. Cancer Res. 22 2003 229 237
85. M. Kawakami, T. Furuhata, Y. Kimura, K. Yamaguchi, F. Hata, K. Sasaki, and K. Hirata Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer Surgery 133 2003 300 308
86. U. Keilholz, M. Willhauck, D. Rimoldi, F. Brasseur, W. Dummer, K. Rass, T. de Vries, J. Blaheta, C. Voit, B. Lethe, and S. Burchill Reliability of reverse transcription-polymerase chain reaction (RT-PCR)- based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group Eur. J. Cancer 34 1998 750 753
87. P. Kienle, M. Koch, F. Autschbach, A. Benner, M. Treiber, M. Wannenmacher, M. von Knebel Doeberitz, M. Buchler, C. Herfarth, and J. Weitz Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer Ann. Surg. 238 2003 324 330
88. M. Kijima, S. Togo, Y. Ichikawa, M. Miura, S. Yamagishi, K. Matsuo, K. Tanaka, H. Masui, T. Ishikawa, H. Ike, and H. Shimada Clinical significance of serum CEA protein and CEA mRNA after resection of colorectal liver metastases Anticancer Res. 25 2005 1327 1332
89. Y. Ko, M. Klinz, G. Totzke, I. Gouni-Berthold, A. Sachinidis, and H. Vetter Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood Clin. Cancer Res. 4 1998 2141 2146
90. M. Koch, P. Kienle, P. Sauer, F. Willeke, K. Buhl, A. Benner, T. Lehnert, C. Herfarth, M. von Knebel Doeberitz, and J. Weitz Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer Surg. Endosc. 18 2004 587 591
91. S.L. Kong, M. Salto-Tellez, A.P. Leong, Y.H. Chan, and E.S. Koay Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications J. Clin. Pathol. 58 2005 839 844
92. T. Kubota Real-time RT-PCR TaqMan of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil Meth. Mol. Med. 111 2005 257 265
93. J. Lacroix, and M.K. Doeberitz Technical aspects of minimal residual disease detection in carcinoma patients Semin. Surg. Oncol. 20 2001 252 264
94. A. Ladanyi, R. Soong, K. Tabiti, B. Molnar, and Z. Tulassay Quantitative reverse transcription-PCR comparison of tumor cell enrichment methods Clin. Chem. 47 2001 1860 1863
95. S. Lassmann, M. Bauer, R. Soong, J. Schreglmann, K. Tabiti, J. Nahrig, R. Ruger, H. Hofler, and M. Werner Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity J. Pathol. 198 2002 198 206
96. S. Lassmann, M. Bauer, R. Rosenberg, H. Nekarda, R. Soong, R. Ruger, H. Hofler, and M. Werner Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression Int. J. Colorectal Dis. 19 2004 87 94
97. T. Lecomte, A. Berger, F. Zinzindohoue, S. Micard, B. Landi, H. Blons, P. Beaune, P.H. Cugnenc, and P. Laurent-Puig Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis Int. J. Cancer 100 2002 542 548
98. K.H. Lee, M.J. McKenna, W.F. Sewell, and F. Ung Ribonucleases may limit recovery of ribonucleic acids from archival human temporal bones Laryngoscope 107 1997 1228 1234
99. R.H. Lekanne Deprez, A.C. Fijnvandraat, J.M. Ruijter, and A.F. Moorman Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions Anal. Biochem. 307 2002 63 69
100. F. Lewis, N.J. Maughan, V. Smith, K. Hillan, and P. Quirke Unlocking the archive-gene expression in paraffin-embedded tissue J. Pathol. 195 2001 66 71
101. G.J. Liefers, A.M. Cleton-Jansen, C.J. van de Velde, J. Hermans, J.H. van Krieken, C.J. Cornelisse, and R.A. Tollenaar Micrometastases and survival in stage II colorectal cancer N. Engl. J. Med. 339 1998 223 228
102. W. Liu, and D.A. Saint A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics Anal. Biochem. 302 2002 52 59
103. S.M. Lledo, E. Garcia-Granero, F. Dasi, R. Ripoli, S.A. Garcia, A. Cervantes, and S.F. Alino Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer Colorectal Dis. 6 2004 236 242
104. L. Losi, B. Baisse, H. Bouzourene, and J. Benhattar Evolution of intratumoral genetic heterogeneity during colorectal cancer progression Carcinogenesis 26 2005 916 922
105. N.R. Mansur, K. Meyer-Siegler, J.C. Wurzer, and M.A. Sirover Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells Nucleic Acids Res. 21 1993 993 998
106. E. Marubini, P. Verderio, C.C. Raggi, M. Pazzagli, and C. Orlando Statistical diagnostics emerging from external quality control of real-time PCR Int. J. Biol. Markers 19 2004 141 146
107. R. Midgley, and D.J. Kerr Adjuvant chemotherapy for stage II colorectal cancer: the time is right! Nat. Clin. Pract. Oncol. 2 2005 364 369
108. M. Miura, Y. Ichikawa, K. Tanaka, M. Kamiyama, Y. Hamaguchi, T. Ishikawa, S. Yamaguchi, S. Togo, H. Ike, S. Ooki, and H. Shimada Real-time PCR (TaqMan PCR) quantification of carcinoembryonic antigen (CEA) mRNA in the peripheral blood of colorectal cancer patients Anticancer Res. 23 2003 1271 1276
109. Y. Miyake, Y. Fujiwara, M. Ohue, H. Yamamoto, Y. Sugita, N. Tomita, M. Sekimoto, H. Shiozaki, and M. Monden Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction Int. J. Oncol. 16 2000 289 293
110. T. Mizuno, H. Nagamura, K.S. Iwamoto, T. Ito, T. Fukuhara, M. Tokunaga, S. Tokuoka, K. Mabuchi, and T. Seyama RNA from decades-old archival tissue blocks for retrospective studies Diagn. Mol. Pathol. 7 1998 202 208
111. C.G. Moertel Chemotherapy for colorectal cancer N. Engl. J. Med. 330 1994 1136 1142
112. R. Moll, A. Lowe, J. Laufer, and W.W. Franke Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies Am. J. Pathol. 140 1992 427 447
113. R. Moll, R. Zimbelmann, M.D. Goldschmidt, M. Keith, J. Laufer, M. Kasper, P.J. Koch, and W.W. Franke The human gene encoding cytokeratin20and its expression during fetal development and in gastrointestinal carcinomas Differentiation 53 1993 75 93
114. M. Mori, K. Mimori, H. Inoue, G.F. Barnard, K. Tsuji, S. Nanbara, H. Ueo, and T. Akiyoshi Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction Cancer Res. 55 1995 3417 3420
115. M. Mori, K. Mimori, H. Ueo, N. Karimine, G.F. Barnard, K. Sugimachi, and T. Akiyoshi Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease Int. J. Cancer 68 1996 739 743
116. M. Mori, K. Mimori, H. Ueo, K. Tsuji, T. Shiraishi, G.F. Barnard, K. Sugimachi, and T. Akiyoshi Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas J. Clin. Oncol. 16 1998 128 132
117. J.W. Mulder, P.M. Kruyt, M. Sewnath, J. Oosting, C.A. Seldenrijk, W.F. Weidema, G.J. Offerhaus, and S.T. Pals Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins Lancet 344 1994 1470 1472
118. M.C. Muller, T. Hordt, P. Paschka, K. Merx, P. La Rosee, R. Hehlmann, and A. Hochhaus Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia Acta Haematol. 112 2004 30 33
119. E.K. Ng, N.B. Tsui, N.Y. Lam, R.W. Chiu, S.C. Yu, S.C. Wong, E.S. Lo, T.H. Rainer, P.J. Johnson, and Y.M. Lo Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals Clin. Chem. 48 2002 1212 1217
120. H.M. Ni, A.F. Leong, D. Cheong, and S.C. Hooi Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase- polymerase chain reaction J. Lab. Clin. Med. 139 2002 59 65
121. H.G. Niesters Quantitation of viral load using real-time amplification techniques Methods 25 2001 419 429
122. H.G. Niesters Molecular and diagnostic clinical virology in real time Clin. Microbiol. Infect. 10 2004 5 11
123. S. Noura, H. Yamamoto, Y. Miyake, B. Kim, O. Takayama, I. Seshimo, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, and M. Monden Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer Clin. Cancer Res. 8 2002 759 767
124. S. Noura, H. Yamamoto, T. Ohnishi, N. Masuda, T. Matsumoto, O. Takayama, H. Fukunaga, Y. Miyake, M. Ikenaga, M. Ikeda, M. Sekimoto, N. Matsuura, and M. Monden Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry J. Clin. Oncol. 20 2002 4232 4241
125. A.N. Oberg, G.E. Lindmark, A.C. Israelsson, S.G. Hammarstrom, and M.L. Hammarstrom Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS Int. J. Cancer 111 2004 101 110
126. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J. Natl. Cancer Inst. 96 2004 1420 1425
127. C. Parr, and W.G. Jiang Quantitative analysis of lymphangiogenic markers in human colorectal cancer Int. J. Oncol. 23 2003 533 539
128. H. Patel, N. Le Marer, R.Q. Wharton, Z.A.J. Khan, R. Araia, C. Glover, M.M. Henry, and T.G. Allen-Mersh Clearance of circulating tumor cells after excision of primary colorectal cancer Ann. Surg. 235 2002 226 231
129. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001 E45
130. M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res. 30 2002 e36
131. C.C. Raggi, P. Verderio, M. Pazzagli, E. Marubini, L. Simi, P. Pinzani, A. Paradiso, and C. Orlando An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man probes Clin. Chem. Lab. Med. 43 2005 542 548
132. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat. Genet. 33 2003 49 54
133. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg, S.R. Hamilton, P. Laurent-Puig, R. Gryfe, L.E. Shepherd, D. Tu, M. Redston, and S. Gallinger Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N. Engl. J. Med. 349 2003 247 257
134. K.A. Rmali, M.C. Puntis, and W.G. Jiang Prognostic values of tumor endothelial markers in patients with colorectal cancer World J. Gastroenterol. 11 2005 1283 1286
135. R. Rosenberg, A. Hoos, J. Mueller, P. Baier, D. Stricker, M. Werner, H. Nekarda, and J.R. Siewert Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients J. Clin. Oncol. 20 2002 1049 1055
136. C. Rubie, K. Kempf, J. Hans, T. Su, B. Tilton, T. Georg, B. Brittner, B. Ludwig, and M. Schilling Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues Mol. Cell Probes 19 2005 101 109
137. A.J. Salsbury The significance of the circulating cancer cell Cancer Treat Rev. 2 1975 55 72
138. T.D. Schmittgen, and B.A. Zakrajsek Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR J. Biochem. Biophys. Meth. 46 2000 69 81
139. R. Schuster, N. Max, B. Mann, K. Heufelder, F. Thilo, J. Grone, F. Rokos, H.J. Buhr, E. Thiel, and U. Keilholz Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers Int. J. Cancer 108 2004 219 227
140. R.D. Smith, B. Brown, P. Ikonomi, and A.N. Schechter Exogenous reference RNA for normalization of real-time quantitative PCR Biotechniques 34 2003 88 91
141. E. Soeth, C. Roder, H. Juhl, U. Kruger, B. Kremer, and H. Kalthoff The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase- chain reaction is related to the stage of disease Int. J. Cancer 69 1996 278 282
142. E. Soeth, I. Vogel, C. Roder, H. Juhl, J. Marxsen, U. Kruger, D. Henne-Bruns, B. Kremer, and H. Kalthoff Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR Cancer Res. 57 1997 3106 3110
143. M. Solanas, R. Moral, and E. Escrich Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors Anal. Biochem. 288 2001 99 102
144. R. Soong, K. Beyser, O. Basten, A. Kalbe, J. Rueschoff, and K. Tabiti Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes Clin. Cancer Res. 7 2001 3423 3429
145. R.G. Souter, C. Wells, D. Tarin, and M.G. Kettlewell Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites Cancer 55 1985 1973 1978
146. E. Spanakis Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls Nucleic Acids Res. 21 1993 3809 3819
147. B. St Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, E. Montgomery, A. Lal, G.J. Riggins, C. Lengauer, B. Vogelstein, and K.W. Kinzler Genes expressed in human tumor endothelium Science 289 2000 1197 1202
148. A. Stahlberg, J. Hakansson, X. Xian, H. Semb, and M. Kubista Properties of the reverse transcription reaction in mRNA quantification Clin. Chem. 50 2004 509 515
149. A. Stahlberg, M. Kubista, and M. Pfaffl Comparison of reverse transcriptases in gene expression analysis Clin. Chem. 50 2004 1678 1680
150. P. Staritz, P. Kienle, M. Koch, A. Benner, M. von Knebel Doeberitz, J. Rudi, and J. Weitz Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients J. Exp. Clin. Cancer Res. 23 2004 633 639
151. A. Szabo, K. Boucher, W.L. Carroll, L.B. Klebanov, A.D. Tsodikov, and A.Y. Yakovlev Variable selection and pattern recognition with gene expression data generated by the microarray technology Math. Biosci. 176 2002 71 98
152. N. Tatsumoto, E. Hiyama, Y. Murakami, Y. Imamura, J.W. Shay, Y. Matsuura, and T. Yokoyama High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer Clin. Cancer Res. 6 2000 2696 2701
153. B. Topal, J.L. Aerts, T. Roskams, S. Fieuws, J. Van Pelt, P. Vandekerckhove, and F. Penninckx Cancer cell dissemination during curative surgery for colorectal liver metastases Eur. J. Surg. Oncol. 31 2005 506 511
154. C. Tricarico, P. Pinzani, S. Bianchi, M. Paglierani, V. Distante, M. Pazzagli, S.A. Bustin, and C. Orlando Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies Anal. Biochem. 309 2002 293 300
155. G. Tsavellas, H. Patel, and T.G. Allen-Mersh Detection and clinical significance of occult tumour cells in colorectal cancer Br. J. Surg. 88 2001 1307 1320
156. D. Vallbohmer, W. Zhang, M. Gordon, D.Y. Yang, J. Yun, O.A. Press, K.E. Rhodes, A.E. Sherrod, S. Iqbal, K.D. Danenberg, S. Groshen, and H.J. Lenz Molecular determinants of cetuximab efficacy J. Clin. Oncol. 23 2005 3536 3544
157. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol. 3 2002 0034.1 0034.11
158. F. Vlems, R. Soong, H. Diepstra, C. Punt, T. Wobbes, K. Tabiti, and G. van Muijen Effect of blood sample handling and reverse transcriptase-polymerase chain reaction assay sensitivity on detection of CK20 expression in healthy donor blood Diagn. Mol. Pathol. 11 2002 90 97
159. F.A. Vlems, J.H. Diepstra, I.M. Cornelissen, T.J. Ruers, M.J. Ligtenberg, C.J. Punt, J.H. van Krieken, T. Wobbes, and G.N. van Muijen Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol. Pathol. 55 2002 156 163
160. F.A. Vlems, A. Ladanyi, R. Gertler, R. Rosenberg, J.H. Diepstra, C. Roder, H. Nekarda, B. Molnar, Z. Tulassay, G.N. van Muijen, and I. Vogel Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol Eur. J. Cancer 39 2003 388 396
161. S.A. Waldman, B. Cagir, J. Rakinic, R.D. Fry, S.D. Goldstein, G. Isenberg, M. Barber, S. Biswas, C. Minimo, J. Palazzo, P.K. Park, and D. Weinberg Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer Dis. Colon Rectum 41 1998 310 315
162. Y. Wang, T. Jatkoe, Y. Zhang, M.G. Mutch, D. Talantov, J. Jiang, H.L. McLeod, and D. Atkins Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J. Clin. Oncol. 22 2004 1564 1571
163. S. Weg-Remers, M. Anders, B. von Lampe, E.O. Riecken, G. Schuder, G. Feifel, M. Zeitz, and A. Stallmach Decreased expression of CD44 splicing variants in advanced colorectal carcinomas Eur. J. Cancer 34 1998 1607 1611
164. J. Weitz, P. Kienle, A. Magener, M. Koch, A. Schrodel, F. Willeke, F. Autschbach, J. Lacroix, T. Lehnert, C. Herfarth, and D.M. von Knebel Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow Clin. Cancer Res. 5 1999 1830 1836
165. R.Q. Wharton, S.K. Jonas, C. Glover, Z.A. Khan, A. Klokouzas, H. Quinn, M. Henry, and T.G. Allen-Mersh Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples Clin. Cancer Res. 5 1999 4158 4163
166. D.K. Wyld, P. Selby, T.J. Perren, S.K. Jonas, T.G. Allen-Mersh, J. Wheeldon, and S.A. Burchill Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20 Int. J. Cancer 79 1998 288 293
167. H. Yamada, W. Ichikawa, H. Uetake, Y. Shirota, Z. Nihei, K. Sugihara, and R. Hirayama Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites Clin. Colorectal Cancer 1 2001 169 173 discussion 174
168. K. Yamaguchi, Y. Takagi, S. Aoki, M. Futamura, and S. Saji Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection Ann. Surg. 232 2000 58 65
169. K. Yoshinare, T. Kubota, M. Watanabe, N. Wada, H. Nishibori, H. Hasegawa, M. Kitajima, T. Takechi, and M. Fukushima Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens Cancer Sci 94 2003 633 638
170. J. Yu, W.D. Shannon, M.A. Watson, and H.L. McLeod Gene expression profiling of the irinotecan pathway in colorectal cancer Clin. Cancer Res. 11 2005 2053 2062
171. H.N. Zavrides, A. Zizi-Sermpetzoglou, D. Panousopoulos, G. Athanasas, I. Elemenoglou, and G. Peros Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer Folia Histochem. Cytobiol. 43 2005 31 36
172. B.R. Zetter The cellular basis of site-specific tumor metastasis N. Engl. J. Med. 322 1990 605 612
173. J. Zhang, and C.D. Byrne Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR Biochem. J. 337 1999 231 241
174. H. Zhong, and J.W. Simons Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia Biochem. Biophys. Res. Commun. 259 1999 523 526
175. V. Zieglschmid, C. Hollmann, B. Gutierrez, W. Albert, D. Strothoff, E. Gross, and O. Bocher Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells Anticancer Res. 25 2005 1803 1810
176. A. Zippelius, P. Kufer, G. Honold, M.W. Kollermann, R. Oberneder, G Schlimok, G. Riethmuller, and K. Pantel Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow J. Clin. Oncol. 15 1997 2701 2708
177. A. Zippelius, R. Lutterbuse, G. Riethmuller, and K. Pantel Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells Clin. Cancer Res. 6 2000 2741 2750